How much funding has Flag Therapeutics raised?

Flag Therapeutics has disclosed $1.4M raised across 2 of its 3 known rounds.

Where is Flag Therapeutics headquartered?

Flag Therapeutics is headquartered in Raleigh, US.

Flag Therapeutics

Raleigh, US · North Carolina corporation

Find your way into Flag Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Flag Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

FLAG Therapeutics develops drug delivery and dosage form solutions for pharmaceutical development and manufacturing, serving biotech and pharmaceutical companies in oncology and rare disease therapeutics.

Biotech Healthtech Medical Devices

Founders & leadership

RUHI AHMEDExecutive

Frank L. Sorgi President and Chief Executive OfficerFrank L. Sorgi is President and CEO of FLAG Therapeutics, which develops drug delivery and dosage form solutions for pharmaceutical and biotech companies focused on oncology and rare disease therapeutics.

Reported raises · per SEC filings

Form D private placements

$1.4M disclosed across 2 of 3 rounds · 2016–2019

▶$72.5KraisedJul 2019 · 2 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

FRANK L. SORGIExecutive Officer, Director
RUHI AHMEDExecutive Officer

Offering amount: $3.5M
Amount sold: $72.5K
First sale: Jun 2019
Incorporated: Corporation, North Carolina
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.3MraisedJan 2019 · 14 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

FRANK L. SORGIExecutive Officer, Director
RUHI AHMEDExecutive Officer

Offering amount: $1.3M
Amount sold: $1.3M
First sale: Mar 2016
Incorporated: Corporation, North Carolina
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

Fate TherapeuticsFate Therapeutics develops investigational cellular immunotherapies to treat autoimmune diseases and cancer. The company is conducting clinical trials on product candidates under strict regulatory and ethical standards.

EvolveImmune TherapeuticsEvolveImmune develops immunotherapy treatments for cancer patients. The company focuses on discovering and developing novel biotherapeutics in immuno-oncology and related immune-mediated diseases.

Epicrispr BiotechnologiesEpic CRISPR develops GEMS (Gene Expression Modulation System), a modular epigenetic editing platform that combines DNA-binding proteins, guide RNAs, and modulator proteins to create genetic medicines. The company serves the biotech/medtech sector with advanced tools for precise gene expression control and disease treatment.

Companies working in the same space as Flag Therapeutics.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2017	$1.5M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Flag Therapeutics do?: FLAG Therapeutics develops drug delivery and dosage form solutions for pharmaceutical development and manufacturing, serving biotech and pharmaceutical companies in oncology and rare disease therapeutics.
How much funding has Flag Therapeutics raised?: Flag Therapeutics has disclosed $1.4M raised across 2 of its 3 known rounds.
Where is Flag Therapeutics headquartered?: Flag Therapeutics is headquartered in Raleigh, US.